SMARCA4-Deficient Undifferentiated Esophageal Carcinoma: A Clinical Case Series and Literature Review
- PMID: 38656564
- PMCID: PMC11347470
- DOI: 10.1007/s12029-024-01060-4
SMARCA4-Deficient Undifferentiated Esophageal Carcinoma: A Clinical Case Series and Literature Review
Abstract
Purpose: Undifferentiated carcinoma of the esophagus (UEC) is a rare malignancy. Deficiency in SMARCA genes, critical for chromatin regulation, has been observed in cases of UEC. Research in UEC is sparse, however, and we present a case series along with a comprehensive review of the literature.
Case series: Case 1 is a 49-year-old female with abdominal pain and dysphagia and esophagogastroduodenoscopy (EGD) showing a friable mass at the gastroesophageal (GE) junction. Biopsies showed a poorly differentiated neoplasm and immunohistochemistry showed loss for SMARCA4. With metastatic disease, she agreed to undergo palliative chemotherapy and radiation, passing away at 4 months. Case 2 is an 88-year-old male with dysphagia, nausea, vomiting, and distal esophageal mass with biopsy showing a malignancy with loss of SMARCA4 expression. Due to extensive metastases, he was counseled on hospice care. Case 3 is a 53-year-old male with extensive alcohol and smoking history presenting with hematemesis, passing away shortly. Posthumous histopathology consistent with undifferentiated SMARCA4-deficient carcinoma of the esophagus. Results of the literature review indicate a predilection towards males (75.0%) and a variable age range (39-88 years). Majority (76.2%) reported with a distal esophagus location. Metastatic disease was common at initial presentation. Median survival was 2.60 months. Some were managed with chemotherapy and radiation.
Conclusions: Research in SMARCA-deficient UEC is very limited. It is more common in men, age is variable, and associated with Barret's esophagus. Further research is necessary to better understand it and to establish treatment guidelines; however, it is clear that SMARCA4-deficient UEC carries a significantly poor prognosis.
Keywords: Chemoradiation; Esophageal cancer; Histopathology; SMARCA genes; Undifferentiated carcinoma.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures



Similar articles
-
SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.Am J Surg Pathol. 2021 Mar 1;45(3):414-420. doi: 10.1097/PAS.0000000000001599. Am J Surg Pathol. 2021. PMID: 33027072
-
SMARCA4-Deficient Undifferentiated Tumor of the Esophagus: Diagnostic Pitfalls in Immunohistochemical Profiles.Int J Surg Pathol. 2024 Oct;32(7):1292-1302. doi: 10.1177/10668969241228290. Epub 2024 Mar 18. Int J Surg Pathol. 2024. PMID: 38497146 Free PMC article. Review.
-
Delayed Diagnosis of SMARCA4-Deficient Undifferentiated Tumor in a Heavy Smoker Male Patient: Discovered Through Bone Sampling, with Extensive Distant Metastases and Concurrent Granulomatous Disease, Leading to Patient Fatality.Int J Surg Pathol. 2025 Apr;33(2):436-441. doi: 10.1177/10668969241260215. Epub 2024 Jun 20. Int J Surg Pathol. 2025. PMID: 38899907
-
A BAFfling liver aspirate: Metastatic high grade SMARCA4 deficient undifferentiated gastroesophageal junction carcinoma masquerading as a hematolymphoid malignancy.Diagn Cytopathol. 2019 Jul;47(7):725-732. doi: 10.1002/dc.24174. Epub 2019 Mar 21. Diagn Cytopathol. 2019. PMID: 30897306
-
Primary Undifferentiated Gallbladder Carcinoma With SMARCA4 Deletion: A Case Report and Review of the Literature.Int J Surg Pathol. 2024 Aug;32(5):1017-1023. doi: 10.1177/10668969231206575. Epub 2023 Oct 29. Int J Surg Pathol. 2024. PMID: 37899615 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous